Background. The diagnosis of uraemic encephalopathy is considered if patients with end-stage renal disease present with neuropsychiatric symptoms. However, cognitive deficits may occur in patients with chronic kidney disease (CKD) long before any overt neurological symptoms can be observed. We hypothesized that cognitive dysfunction in patients with CKD both, treated and untreated by haemodialysis, may correspond to metabolic changes in distinct brain regions. Methods. We performed magnetic resonance spectroscopy (MRS) ( 1 H-MRS) of the brain in 23 non-dialysed patients with CKD (Stages 4-5) and in 15 haemodialysed patients. Healthy controls (n ¼ 63) adjusted for age and education were recruited from the social environment of the patients' population. Attention, learning and memory were assessed by psychometric testing. Results. MRS alterations were predominantly found in the white matter. Concentrations of creatine-containing compounds (Cr) were decreased in dialysed and nondialysed patients. Choline concentration (Cho) and combined N-acetylaspartate and N-acetylaspartylglutamate concentration (NAx) were reduced only in dialysed patients. Disturbance in memory and learning ability as well as attention deficits were observed in both patient groups. Of note, attention deficits were more severe in dialysed patients. MRS results correlated with attention deficits in dialysed patients. Conclusions. CKD patients without clinical signs of uraemic encephalopathy showed metabolic disturbances in distinct brain regions as well as cognitive impairments. Haemodialysis was accompanied with more severe cognitive dysfunction and metabolic alternations than CKD alone. Although the small sample size limits the interpretation of the data, a negative impact of haemodialysis on cognitive function must be considered.
Introduction
Uraemic encephalopathy presents with manifold symptoms ranging from headache, visual abnormalities, tremor, asterixis, multifocal myoclonus, chorea and seizure to clouding of consciousness, delirium and coma [1] . Even in the absence of overt neurological changes, cognitive impairment can be detected by the use of psychometric tests [1] . Deficits of intelligence, memory, attention and executive function have been described in dialysed and non-dialysed patients with chronic kidney disease (CKD) [2, 3] . The frequency of cognitive disturbance is probably higher than expected in the past and can be detected even in moderate CKD [4] [5] [6] .
The pathophysiology of uraemic encephalopathy is poorly understood and the name 'uraemic' is historical and does not depict the cause of the disease. The accumulation of neurotoxic metabolites, hormonal disturbances and an imbalance in excitatory and inhibitory neurotransmitters have been suggested to play a role in its pathogenesis [1, 7] . Haemodialysis applied in end-stage renal disease does not always ameliorate neurological and cognitive symptoms [8] . Although the cause of this phenomenon is not completely understood, insufficient elimination of toxic substances (like middle molecules), fluctuation of extracellular fluid volume and exposure to bio-incompatible materials are discussed to contribute to a dialysis-associated syndrome [8] .
A few studies indicate brain metabolite alterations as a consequence of CKD and haemodialysis without investigating relationship between metabolic disturbances and cognitive dysfunction [9] [10] [11] [12] . The presented study is the first that aimed to compare metabolic alterations to cognitive impairments in dialysed and non-dialysed patients with chronic renal dysfunction.
Materials and methods

Subjects
The study population consisted of two groups: 23 non-dialysed patients with CKD Stages 4 and 5 and 15 dialysed patients. Patients were recruited from the nephrological outpatient clinic of Hannover Medical School and the Centre of Haemo in Hannover. Underlying diseases in the nondialysed vs and dialysed group respectively were glomerulonephritis (10 vs 6), chronic pyelonephritis (1 vs 1), hypertensive nephropathy (2 vs 2), reflux nephropathy (1 vs 2), amyloidosis (one non-dialysed patient), polycystic kidney disease (three non-dialysed patients), Alport syndrome (one dialysed patient), Henoch-Schönlein purpura (one dialysed patient), analgesic nephropathy (one non-dialysed patient), chronic interstitial nephritis (two non-dialysed patients) or unknown cause (2 vs 2).
Duration of the disease averaged 16 years for both groups (nondialysed patients 1.5-50 and dialysed 2-65 years). Patients were excluded in case of liver disease, diabetes mellitus, high-grade peripheral vascular disease, coronary failure treated with interventional procedures, stroke, subcortical arteriosclerotic encephalopathy, other neurological or psychiatric diseases, haemoglobin concentration <9 g/dL and use of medication influencing central nervous system. The 'modification of diet in renal disease' equation was used to estimate glomerular filtration rate (GFR). The GFR of non-dialysed patients ranged from 4.1 mL/min/1.73 m 2 to 27.8 mL/min/1.73 m 2 (median 13.5 mL/min/1.73 m 2 ). Patients in the dialysis group had undergone haemodialysis for 1-27 years (median 7 years) with a current dialysis frequency of three times a week. The studies were performed the day after haemodialysis. Healthy controls were recruited from the social environment of the patient population and the examiners. Twenty-three controls underwent magnetic resonance spectroscopy (MRS) and 40 psychometric testing. All subjects underwent detailed neurological examination. The study was conducted in accordance with the ethical guidelines laid down in the Declaration of Helsinki in 1975 (revised in 2000) and approved a priori by the local ethics committee. All candidates gave written informed consent. Details with regard to age, gender and years of education are provided in Table 1 .
Neuroimaging
Single voxel point-resolved 1 H-MRS was performed on a 1.5-T MR Imaging unit (Signa Horizon; GE-Medical Systems, Milwaukee, WI) after the conventional magnetic resonance imaging (MRI) examination by using a standard receiver head coil in all cases. A volume of interest, measuring~8 cm 3 (2 3 2 3 2 cm), was positioned within the parieto-occipital white matter, the occipital grey matter, the basal ganglia and the pons. The selection of the region of interest was guided manually and choice of the side was free. For all spectra, a short TE-stimulated echo acquisition mode (STEAM) technique (1500 TR, 30 TE; 128 signal averages) was used.
1 H-MR spectra were analysed using the PROBE/SV software (GE Medical Systems), which provides automated global and local shimming and chemical shift selective water suppression [13] . The PROBE/SV software provides values for the metabolite ratios of N-acetylaspartate (NAA), choline-containing compounds (Cho, as the sum of free choline, choline phosphates and choline phosphatides) and myo-Inositol (mI) in relation to creatine (Cr, as the sum of creatine and phosphocreatine). This conventional semi-quantitative approach is based on the questionable assumption that creatine concentrations would remain unchanged irrespective of a possible brain pathology. Therefore, an additional evaluation method was used for spectrum analysis to obtain absolute values for metabolite quantification. The applied LCModel software [14] yields values for the concentration of Cho, Cr, mI and NAA, N-acetylaspartylglutamate (NAAG) as well as sum values for combined spectra of glutamine and glutamate (GLx) and N-acetylaspartate and N-acetylaspartylglutamate (NAx). We used the latter combined signal intensities because glutamine and glutamate are virtually indistinguishable at 1.5 T, which applies to N-acetylaspartate and N-acetylaspartylglutamate equally.
Psychometry
Several tests were used to measure the speed and efficiency of cognitive function. The set of psychometric tests included the following: Luria's List of Words [15] , Word-Figure-Memory-Test [16] , Picture memory test [17] , Rey-Osterreith complex figure test [18] , Test battery for assessment of attention processing (TAP, with subtests: Alertness, Working Memory, visual/acoustic Divided Attention, Vigilance, Crossmodal Integration, go/nogo, Attention Shift) [19] , cancelling d-test [20] , Line Tracing Test [21] , Serial Dotting Test [21] , Digit Symbol Test [21] and Trail Making Test A and B [21] .
Statistical analysis
Data are presented as median values if not otherwise stated. Applying the closed testing procedure to correct for multiple testing, the Kruskal-Wallis test followed by the two-sided Mann-Whitney U-test was used for analysing differences between control and patient groups. Spearman's test was used for correlation analysis. A statistically significant difference was assumed at P < 0.05. All statistical analyses described above were performed using the software programme SPSS.
Results
The study groups did not differ in age and years of education; however, there were more female subjects in our control groups. The duration of the diseases was comparable in both patient groups. All subjects had normal MRI findings without any evidence of lacunar infarction or subcortical arteriosclerotic encephalopathy. Only three patients presented with mild hyporeflexia and one with mild paraesthesia in the dialysed group as a sign of polyneuropathy. None of the patients had signs of overt uraemic encephalopathy. Magnetic resonance spectroscopy MRS alterations were found in both patient groups compared to controls; however, significant differences between patient groups could only be detected for NAA/Cr and choline. All measured metabolite concentrations are presented in Table 2 .
Non-dialysed patients
There were no significant differences between controls and non-dialysed patients in metabolite ratios. The sole significant changes in absolute metabolite concentrations were found for creatine in parieto-occipital white matter compared to healthy controls (P ¼ 0.007). No other significant Cr difference was detectable, although the mean creatine concentrations were lower in non-dialysed patients than in controls in all studied regions ( Figure 1A ).
Dialysed patients
In dialysed patients, NAA/Cr ratios in the occipital grey matter were decreased compared to non-dialysed patients (P ¼ 0.016) and healthy controls (P ¼ 0.008). Ml/Cr ratio was increased in dialysed patients in the parieto-occipital white matter (P ¼ 0.002) and in the pons (P ¼ 0.001) compared to healthy controls. Changes of absolute metabolite concentrations were found particularly in the parieto-occipital white matter in dialysed patients. NAx concentrations were significantly decreased in this region compared to healthy controls (P ¼ 0.003) ( Figure 1B) . Cr concentrations were decreased in the parieto-occipital white matter (P ¼ 0.005) and basal ganglia (P ¼ 0.016) compared to healthy controls ( Figure 1A ). Dialysed patients showed lower choline concentrations in the parieto-occipital white matter than healthy controls (P ¼ 0.005) and non-dialysed patients (P ¼ 0.008) ( Figure 1C ).
Psychometric testing
Cognitive impairments were found for memory, learning and attention. Psychomotor functions remained unchanged.
Non-dialysed patients
Two memory and learning tests-Lurias' List of Words and the Word-Figure-Memory-Test-revealed significant differences between healthy controls and non-dialysed patients. In first (P ¼ 0.01), second (P ¼ 0.013), fourth (P ¼ 0.004) and fifth (P ¼ 0.001) recall of Lurias' List, non-dialysed patients performed worse than healthy controls. Patients showed a reduction of the learning aptitude compared to healthy controls (P ¼ 0.005) (Figure 2A) . Non-dialysed patients scored lower in all subtests of WordFigure-Memory-Test [concrete and abstract words (P ¼ 0.004), concrete and abstract pictures (P < 0.001), concrete pictures and words (P < 0.001), abstract pictures and words (P ¼ 0.001)] and the sum score (P < 0.001) ( Figure 2B ). Trail Making Test B (P < 0.001) and some of the subtests of the TAP battery revealed attention deficits in non-dialysed patients compared to healthy controls: reaction time in Crossmodal Integration was prolonged (P ¼ 0.013), the number of misses in Working Memory (P ¼ 0.004) and the number of errors in Crossmodal Integration (P ¼ 0.007) were increased. Metabolite concentrations were measured in the parieto-occipital white matter (pw), occipital grey matter (og), basal ganglia (bg) and in the pons. Numbers in brackets indicate the number of subjects included into data analysis. Significant differences (P < 0.05): values in bold refers to compared to healthy controls and values in underline refers to compared to non-dialysed patients.
Dialysed patients
Dialysed patients performed worse in the first (P ¼ 0.002) and second (P ¼ 0.004) recall of Lurias' List and had a lower learning aptitude (P ¼ 0.002) than healthy controls ( Figure  2A ). They also scored lower in Word-Figure-Memory-Test [concrete and abstract words (P ¼ 0.005), concrete and abstract pictures (P ¼ 0.002), concrete pictures and words (P ¼ 0.002), abstract pictures and words (P ¼ 0.001) and sum score (P < 0.001)] than the controls ( Figure 2B ).
Attention deficits were more pronounced in dialysed patients than in non-dialysed patients. Like the non-dialysed patients, the dialysed patients performed worse than healthy controls in the Trail Making Test B (P ¼ 0.003). In addition, they achieved worse results than healthy controls in some subtests of the TAP battery. Dialysed patients had more errors in Vigilance (P ¼ 0.012) and Crossmodal Integration (P < 0.001), longer reaction time in Divided Attention (P ¼ 0.012) and Attention Shift (P ¼ 0.006) and more omissions in Working Memory (P ¼ 0.009) than the healthy controls.
Correlation between MRS alterations and psychometric results
No correlations were found between MRS changes and psychometric test results in non-dialysed patients. In dialysed patients, attention deficits correlated with metabolic changes in the parieto-occipital white matter. Creatine as well as choline concentrations correlated negatively with the number of errors in the Vigilance test (r ¼ À0.817, P ¼ 0.007; r ¼ À0.817, P ¼ 0.007, respectively) ( Figure 3A and B). Thus, lower concentrations of those metabolites were accompanied with higher number of errors. Additionally, lower concentrations of NAx were associated with higher number of errors in Crossmodal Integration (r ¼ À0.715, P ¼ 0.046) ( Figure 3C ).
Discussion
The aim of the present study was to characterize metabolic changes in the brain and patterns of cognitive dysfunction in patients with severe CKD treated and untreated by haemodialysis.
Only few studies provide comprehensive MRS data in patients with CKD. Most reports describe an increase in myoinositol and choline [9, 11, 12] , partly accompanied by a decrease in NAA [9, 11] analysing metabolite ratios to creatine [9] [10] [11] [12] . This is in accordance with our findings for metabolite ratios compared to creatine (Table 2A) . Since creatine changes in aging [22] as well as several brain diseases such as Alzheimer's disease [23] or multiple sclerosis [24] , absolute metabolite concentrations may reflect metabolite changes more accurately in certain diseases and hence both absolute and relative metabolites were measured in this study. Indeed, we found a decrease of creatine concentrations in each of the four examined brain regions in our patients compared to healthy controls, albeit significant differences were only found in white matter and basal ganglia ( Figure 1A ). These changes were more pronounced in dialysed patients, implying a link between progressing kidney disease and decreased creatine concentrations. Previously, only Michaelis et al. analysed absolute brain metabolite concentrations in CKD patients with and without haemodialysis. Although they did not find significant differences in creatine concentrations between healthy controls, patients on haemodialysis and non-dialysed patients with CKD, white matter creatine concentrations in both patient groups were lower than in controls [12] . The underlying cause for these changes is not completely clear. Creatine/phosphocreatine is a surrogate marker for energy metabolism and is localized in neurons and glia cells. Creatine levels may decrease or increase in brain lesions depending on the nature of the disease. Tissue lesions with a reduced cellularity, for example, show a reduced creatine signal. Thus, a decrease of the creatine concentration is thought to be associated with neuronal alteration or oligodendrocyte disturbance [24] . Both reasons seem plausible in our patients with CKD. Of note, vigilance-the basal function of attention processing-was significantly correlated to creatine concentrations in the parieto-occipital white matter in dialysed patients ( Figure 3A) .
Furthermore, we could show a decrease of NAA and NAAG (NAx) in dialysed patients compared to healthy controls. NAA is a marker for neuronal integrity and reflects metabolic and structural neuronal changes [24, 25] . NAAG modulates glutamatergic neurotransmission and may have a role in neuroprotection and synaptic plasticity [25] . Reversible reduction in NAx has been described in some pathological conditions, including multiple sclerosis [26] and amyotrophic lateral sclerosis [27] suggesting that the reduction of NAA reflects not necessarily neuronal loss but also reversible neuronal dysfunction secondary to persistent metabolic derangement [25] . Since the separate measurement of the respective metabolites is difficult due to methodological problems, often the combined measurement of both metabolites (NAx) has been used [28] . In our study, NAA/Cr ratios in the occipital grey matter and NAx concentrations in the parieto-occipital white matter were decreased in dialysed patients. Previously reported NAA/Cr ratios were inconsistent. Geissler et al. [9] showed a decrease of NAA/Cr ratios in grey and white matter in dialysis patients, whereas Sasaki et al. [10] reported stable NAA/Cr ratios. Discrepancies between previous studies can be explained by both different study populations and study designs, and the inherent shortcoming of the semi-quantitative approach to analyse and construe metabolite changes. Our data imply that a decline of NAx concentrations may also be a consequence of the dialysis procedure itself. The decrease of NAx correlated with deficits in executive function in dialysed patients ( Figure 3C ).
In addition to alterations in creatine and NAx metabolites, the choline concentration within the white matter was altered in dialysed patients both compared to non-dialysed patients and healthy controls ( Figure 1C ). MRS choline peaks likely represent various cell membrane precursor and breakdown products, including phosphocholine, glycerophosphocholine and phosphatidylcholine. Choline is assumed to represent myelin metabolism but has also been considered to play a role as cerebral osmolyte [29] . A decrease of the cerebral choline concentration has also been observed in hepatic encephalopathy [30] and was interpreted as indication of altered cellular membrane turnover or cell swelling [31] . In our study, choline reduction like creatine reduction correlated with basal attention deficits in dialysed patients ( Figure 3B ) that compares well with findings of Weissenborn et al. [30] in patients with liver cirrhosis and hepatic encephalopathy.
A growing body of evidence suggests that learning and memory is impaired in patients with CKD treated and untreated by haemodialysis [32] [33] [34] [35] . However, in previous studies, only few tests were used. Thus, a characterization of the pattern of cognitive dysfunction in patients with CKD was lacking. We showed disturbances in vigilance, the learning ability for auditory presented items, the retrieval of visually presented verbal and figural items and deficits in higher executive functions. Learning and memory difficulties were decreased to a similar degree in dialysed and non-dialysed patients (Figure 2 ). Attention deficits in working memory and divided attention were also found in both patient groups. Dialysed patients had in addition difficulties with long-term attention and cognitive flexibility. This pattern of cognitive dysfunction is widely comparable to that found in patients with white matter disease [36] . In fact, the spectroscopic and the psychometric data suggest especially alterations of the white matter in middle-aged CKD patients despite of a normal presentation of the white matter in conventional MRI.
Recently, a study in nursing home residents with CKD has shown that the initiation of dialysis is associated with a substantial and sustained decline in functional status [37] . One may assume that the memory and learning as well as the attention deficits seen in our investigation in relatively young (middle aged) dialysis patients might play an important role in mediating those detrimental effects in elderly patients suffering already from severe coexisting conditions.
The sample size of this study limits our ability to investigate the influence of confounding factors such as medication and the aetiology of CKD. Furthermore, it is important to note that while this study is useful in identifying between-group differences in cognitive performance as well as metabolic alterations, changes across the course of the disease can only be inferred from a longitudinal study design. The goal of our study was to characterize cognitive dysfunction in uraemic state; therefore, we excluded other factors such as diabetes mellitus and advanced arteriosclerosis that can influence cognitive function per se. However, since diabetes mellitus is the most common aetiology in CKD, our study might not be representative and has potentially underestimated cognitive dysfunction in a natural cohort of CKD patients.
In good corroboration with previous data, psychometric and spectroscopic changes were not correlated with the duration of kidney disease, dialysis or GFR [32, 33] . Delayed diagnosis, different underlying renal pathologies, frequency and duration of haemodialysis could all contribute to these findings. However, due to the limited number of patients, we cannot exclude any non-linear correlations [5, 38] .
In conclusion, we characterized cognitive dysfunction pattern and brain metabolite disturbances in patients with severe CKD without clinical signs of uraemic encephalopathy. Memory and learning as well as attention deficits characterize both patient populations studied-those patients without haemodialysis and those on haemodialysis. A decrease in creatine concentrations in several studied brain regions is already detectable in non-dialysed CKD patients. Unexpectedly, haemodialysis seems neither capable to revoke cognitive dysfunctions nor metabolic changes in the brain. On the contrary, dialysis is accompanied with more pronounced attention deficits associated with creatine, choline and NAx decreases in the brain in CKD patients.
